Interaction of MTNR1B Genotype and Type of Breakfast (Protein-enriched v Carbohydrate-rich) on Postprandial Glucose Response.
1 other identifier
interventional
60
1 country
1
Brief Summary
The risk version of the MTNR1B gene (which codes for a melatonin receptor) has been associated with type II diabetes (T2D) and associated physiological markers. People with the risk version of the gene have reduced secretion of insulin when melatonin levels are high (between evening and morning) and impaired glucose tolerance when they eat late. Previous research suggests eating a protein enriched breakfast can improve glucose response. Therefore, the present study will investigate if the version of the MTNR1B gene that people have is associated with their glucose response after breakfast. Also, whether a protein enriched breakfast improves glucose response in participants with the risk version of the gene. Measures of glucose response collected over the two-week duration of the study will be compared between groups with the different versions of the gene. These findings can be used to provide personalised nutrition advice which may reduce the risk of T2D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2024
CompletedStudy Start
First participant enrolled
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
February 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedMay 16, 2025
May 1, 2025
6 months
August 1, 2024
May 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Glucose response
Area under the curve
120 minutes
Secondary Outcomes (3)
CGM metrics - mean glucose
14 days
CGM metrics - Time in range
14 days
CGM metrics - glycaemic variability
14 days
Study Arms (2)
Protein enriched breakfast
EXPERIMENTALHigh carbohydrate breakfast
ACTIVE COMPARATORInterventions
Breakfast in one condition will be high carbohydrate and in the other protein enriched
Eligibility Criteria
You may qualify if:
- aged 18-48 years\*, not diabetic, not sleep disorder, not relevant medication (weight loss, sleeping, melatonin), not restricted diet, not allergic to oats, milk, wheat, barley or soya, not implanted medical device, such as pacemakers.
You may not qualify if:
- aged \< 18 or \> 48 years, diabetic, sleep disorder, eating disorder, taking relevant medication (weight loss, sleeping, melatonin), following a restricted diet, implanted medical device, such as pacemakers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Mary's University
London, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Breakfast condition - high carbohydrate or protein enriched
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2024
First Posted
February 12, 2025
Study Start
September 9, 2024
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share